sensit
rapid
detect
respiratori
virus
need
surveil
investig
epidemiolog
link
case
util
rapid
antigenbas
method
detect
common
respiratori
virus
confirm
caus
outbreak
well
establish
howev
nucleic
acid
amplif
test
nat
offer
benefit
antigen
culturebas
procedur
main
advantag
sensit
rang
pathogen
detect
import
understand
chang
test
methodolog
alter
respiratori
viru
detect
inform
epidemiolog
studi
virus
influenza
influenza
b
respiratori
syncyti
viru
nat
offer
enhanc
sensit
antigen
assay
still
identifi
season
peak
import
predict
diseas
manag
timesensit
prophylaxi
virus
rhinovirus
coronavirus
human
bocaviru
parainfluenza
viru
type
cultur
antigenbas
procedur
avail
andor
lack
sensit
thu
target
would
miss
nat
includ
test
surveil
outbreak
investig
respiratori
virus
identifi
need
expand
surveil
evalu
new
technolog
autom
beyond
currentlyavail
diagnost
address
detect
broad
rang
potenti
pathogen
monitor
surveil
wellrecogn
respiratori
virus
potenti
zoonot
threat
import
manag
minim
commun
impact
heeney
enhanc
surveil
diagnosi
respiratori
ill
potenti
reduc
healthcar
cost
enorm
halasa
et
al
esposito
et
al
still
signific
gap
knowledg
concern
rang
pathogen
caus
respiratori
infect
diseas
mani
case
go
undiagnos
respiratori
viru
detect
diagnosi
complex
wide
rang
virus
pathogen
present
clinic
symptom
empir
treatment
patient
without
clear
diagnosi
may
result
implement
expens
disrupt
public
health
measur
well
lead
increas
spread
diseas
season
respiratori
virus
well
recogn
viral
surveil
laboratorybas
diagnost
import
guid
time
prophylaxi
intervent
respiratori
syncyti
viru
rsv
peak
winter
month
year
although
start
finish
season
vari
alonso
et
al
import
track
season
plan
prophylaxi
vulner
children
influenza
adequ
surveil
import
design
appropri
vaccin
plan
time
prophylaxi
detect
novel
virus
mani
viral
caus
respiratori
outbreak
use
nat
enabl
us
greater
understand
rang
type
virus
respons
provid
broadest
possibl
valu
laboratori
diagnosi
respiratori
tract
infect
gener
inform
viral
epidemiolog
well
provid
clinic
inform
mani
laboratori
diagnosi
respiratori
viru
infect
reli
heavili
direct
fluoresc
antigen
dfa
assay
rapid
antigen
detect
method
modifi
cultur
procedur
rapid
turnaround
dfa
mean
method
still
use
influenza
viru
ifv
ifvb
rsv
provid
good
nasopharyng
np
sampl
taken
posit
result
use
cohort
vulner
individu
treatment
individu
manag
potenti
outbreak
dfa
howev
sensit
nat
target
addit
case
identifi
use
method
dfaneg
np
sampl
use
cultur
versu
nat
adjunct
diagnost
approach
especi
nonnp
sampl
depend
laboratori
capac
setup
cultur
method
theori
catch
need
preconceiv
idea
like
caus
practic
cultur
sensit
often
neg
mani
picornavirus
coronavirus
human
metapneumoviru
hmpv
human
bocaviru
hbov
recogn
caus
respiratori
symptomolog
diseas
commun
hospit
choic
nat
appropri
facil
avail
obviou
maximum
sensit
requir
test
one
target
lee
et
al
cultur
reserv
sampl
alreadi
screen
given
posit
result
dfa
nat
isol
need
analysi
detail
elsewher
howev
broad
rang
respiratori
virus
bacteria
caus
similar
symptom
make
set
nat
complex
full
diagnost
test
repertoir
attempt
multiplex
amplif
method
suspens
microarray
detect
may
one
diagnost
enhanc
use
sensit
surveil
outbreak
investig
figur
provid
data
posit
result
ifva
fig
ifvb
rsv
piv
epidemiolog
data
accumul
recentlyidentifi
respiratori
virus
easili
identifi
except
nat
studi
multipl
year
demonstr
season
impact
hmpv
eg
bosi
et
al
bouscambertduchamp
et
al
sloot
et
al
dare
et
al
manoha
et
al
pabbaraju
et
al
sivaprakasam
et
al
van
den
hoogen
picornavirus
eg
jartti
et
al
arden
et
al
jacqu
et
al
winther
et
al
coronavirus
eg
vallet
et
al
birch
et
al
chiu
et
al
kaiser
et
al
arden
et
al
esposito
et
al
gerna
et
al
hbov
identifi
frequent
respiratori
sampl
young
children
associ
high
coinfect
rate
eg
arden
et
al
arnold
et
al
bastien
et
al
et
al
adenovirus
recogn
import
caus
respiratori
infect
commun
respons
outbreak
see
de
mezervil
et
al
russel
et
al
surveil
measur
virus
larg
reli
culturebas
procedur
fact
cultur
rel
sensit
although
slow
detect
adenovirus
unlik
dfa
lack
sensit
viru
nat
adenovirus
advantag
speed
identif
individu
case
etiolog
diagnosi
outbreak
shown
figur
respiratori
outbreak
epidemiolog
link
case
occur
winter
month
octobermarch
alberta
use
current
diagnost
test
algorithm
identifi
ifva
ifvb
piv
rsv
hmpv
adenovirus
abl
make
etiolog
diagnosi
outbreak
investig
tabl
despit
chang
test
methodolog
ifva
still
commonli
recogn
caus
respiratori
viru
outbreak
figur
tabl
although
ifvb
rsv
piv
hmpv
adenoviru
also
associ
also
shown
dollner
et
al
faden
et
al
honda
et
al
russel
et
al
boivin
et
al
addit
alberta
consider
number
outbreak
associ
ei
epidemiolog
investig
mix
infect
clear
enhanc
test
particularli
use
nat
allow
identif
mix
respiratori
viru
outbreak
sampl
contain
one
detect
target
breakdown
result
respiratori
outbreak
given
tabl
although
use
combin
antigen
nat
enabl
viral
etiolog
diagnosi
made
major
outbreak
alberta
still
epidemiolog
link
case
viru
identifi
use
current
test
algorithm
undiagnos
outbreak
probabl
involv
virus
bacteria
part
routin
test
panel
rhinovirus
hick
et
al
kiang
et
al
coronavirus
birch
et
al
ifvc
matsuzaki
et
al
import
use
best
avail
diagnost
tool
identifi
common
unusu
respiratori
virus
caus
individu
symptomat
case
commun
well
outbreak
investig
particularli
necessarili
predict
year
year
econom
cost
respiratori
viru
outbreak
appar
model
achonu
et
al
halasa
et
al
russel
et
al
use
nat
enhanc
detect
ifva
ifvb
rsv
howev
antigenbas
test
may
still
use
virus
whichev
approach
routin
diagnost
laboratori
season
peak
viru
activ
identifi
use
dfa
nat
identifi
piv
throughout
year
without
particular
season
previou
studi
identifi
piv
season
piv
piv
tend
exclud
particular
year
fri
et
al
use
nat
activ
surveil
vulner
group
identifi
piv
case
seen
antigen
culturebas
procedur
inform
carriag
infect
piv
use
crosstransmiss
may
difficult
prevent
pivinfect
immunocompromis
patient
requir
therapi
dignan
et
al
piv
may
import
caus
outbreak
lau
et
al
would
identifi
effici
antigen
cultur
method
despit
lack
associ
adenovirus
larg
number
outbreak
alberta
group
virus
caus
signific
diseas
vulner
individu
faden
et
al
well
outbreak
econom
impact
militari
naval
train
centr
russel
et
al
like
piv
adenovirus
increasingli
recogn
immunocompromis
individu
advent
detail
surveil
sensit
laboratori
test
nat
treatment
infect
may
consid
immunocompromis
patient
rapid
diagnost
turnaround
may
becom
import
rhinovirus
routin
identifi
without
use
nat
symptom
exacerb
associ
outbreak
much
greater
previous
recogn
group
virus
hick
et
al
kusel
et
al
khetsuriani
et
al
kiang
et
al
miller
et
al
distinct
season
detail
surveil
use
nat
undertaken
winther
et
al
coronavirus
underdiagnos
unless
nat
util
virus
link
outbreak
expand
test
undertaken
vallet
et
al
birch
et
al
chiu
et
al
kaiser
et
al
arden
et
al
esposito
et
al
gerna
et
al
khetsuriani
et
al
date
studi
hbov
infect
reveal
predomin
infect
young
children
without
coinfect
pathogen
arden
et
al
arnold
et
al
bastien
et
al
et
al
detail
surveil
probabl
use
nat
allow
us
assess
full
clinic
impact
viru
detect
surveil
analysi
respiratori
virus
well
establish
use
antigen
cultur
nucleic
acidbas
test
identif
novel
respiratori
virus
need
enhanc
etiolog
diagnosi
individu
case
epidemiolog
link
outbreak
led
reevalu
current
test
method
dfa
cultur
still
limit
term
sensit
rang
viral
pathogen
identifi
individu
targetspecif
nat
enhanc
sensit
technolog
enhanc
need
broad
viru
amplif
detect
multiplex
amplif
procedur
mciroarray
detect
product
may
one
way
undertak
broadspectrum
viral
surveil
outbreak
investig
studi
need
confirm
suitabl
technolog
particular
purpos
none
declar
